Eurand gets Serono exec
Executive Summary
Eurand appoints Constantinos Efthymiopoulos as chief scientific officer, effective Jan. 9, 2006. Efthymiopoulos will be responsible for Eurand's global research & development, clinical development and regulatory affairs. Efthymiopoulos previously served as corporate VP and dermatology therapeutic area head at Serono, where he was responsible for the launch of Raptiva. He has also held scientific and managerial positions at GlaxoWellcome...